1 research outputs found
Structure–Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents
Forty-three
1,5-diheteroaryl-1,4-pentadien-3-ones were designed
as potential curcumin mimics, structurally featuring a central five-carbon
dienone linker and two identical nitrogen-containing aromatic rings.
They were synthesized using a Horner–Wadsworth–Emmons
reaction as the critical step and evaluated for their cytotoxicity
and antiproliferative activities toward both androgen-insensitive
and androgen-sensitive prostate cancer cell lines and an aggressive
cervical cancer cell line. Most of the synthesized compounds showed
distinctly better in vitro potency than curcumin in the four cancer
cell lines. The structure–activity data acquired from the study
validated (1<i>E</i>,4<i>E</i>)-1,5-dihereroaryl-1,4-pentadien-3-ones
as an excellent scaffold for in-depth development for clinical treatment
of prostate and cervical cancers. 1-Alkyl-1<i>H</i>-imidazol-2-yl,
ortho pyridyl, 1-alkyl-1<i>H</i>-benzoÂ[<i>d</i>]Âimidazole-2-yl, 4-bromo-1-methyl-1<i>H</i>-pyrazol-3-yl,
thiazol-2-yl, and 2-methyl-4-(trifluoromethyl)Âthiazol-5-yl were identified
as optimal heteroaromatic rings for the promising in vitro potency.
(1<i>E</i>,4<i>E</i>)-1,5-BisÂ(2-methyl-4-(trifluoromethyl)Âthiazol-5-yl)Âpenta-1,4-dien-3-one,
featuring thiazole rings and trifluoromethyl groups, was established
as the optimal lead compound because of its good in vitro potency
and attractive in vivo pharmacokinetic profiles